Terconazole
-
Terconazole
structure -
-
CAS No:
67915-31-5
-
Formula:
C26H31Cl2N5O3
-
Chemical Name:
Terconazole
-
Synonyms:
Piperazine,1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-,rel-;Piperazine,1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-,cis-;rel-1-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)piperazine;Triaconazole;Terconazole;Gyno-Terazol;Terazol;Terazol Cream & Suppositories;R 42470;Fungistat;Tercospor;NSC 331942;(±)-Terconazole;Termayazole;85058-79-3
- Categories:
-
CAS No:
Description
Terconazole is a broad-spectrum antifungal medication for the treatment of vaginal yeast infection.
Solid
(2R,4S)-terconazole is a 1-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine in which positions 2 and 4 of the 1,3-dioxolane moiety have R and S configuration, respectively. It is an enantiomer of a (2S,4R)-terconazole.|Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials.
Terconazole Basic Attributes
532.46
532.46
267-751-6
760361
DTXSID2045498
G - Genito urinary system and sex hormones
2934990002
Characteristics
64.9
4.8
white
1.35g/cm3
126.3 °C
681.8°C at 760 mmHg
366.2ºC
1.64
DMSO: soluble 1mg/mL
2-8°C
Safety Information
NONH for all modes of transport
3
36/37/38-53
26
TL3564600
Xi
P305 + P351 + P338
H315-H319-H335-H413
|Warning|H302 (59.57%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 94 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
The oral LD50 values were found to be 1741 and 849 mg/kg for the male and female in rat.
94.9%
Drug Information
For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.|FDA Label
Terconazole is a triazole antifungal agent available for intravaginal use. It is structurally related to imidazole-derivative antifungal agents, although terconazole and other triazoles have 3 nitrogens in the azole ring. By inhibiting the 14-alpha-demethylase (lanosterol 14-alpha-demethylase), Terconazole inhibits ergosterol synthesis. Depletion of ergosterol in fungal membrane disrupts the structure and many functions of fungal membrane leading to inhibition of fungal growth.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
Following intravaginal administration of terconazole in humans, absorption ranged from 5-8% in three hysterectomized subjects and 12-16% in two non-hysterectomized subjects with tubal ligations|Following oral (30 mg) administration of 14C-labelled terconazole, excretion of radioactivity was both by renal (32-56%) and fecal (47-52%) routes.
Systemically absorbed drug appears to be rapidly and extensively metabolized. Terconazole primarily undergoes oxidatative N- and O-dealkylation, dioxolane ring cleavage, and conjugation.
6.9 hours (range 4.0-11.3)
Terconazole may exert its antifungal activity by disrupting normal fungal cell membrane permeability. Terconazole and other triazole antifungal agents inhibit cytochrome P450 14-alpha-demethylase in susceptible fungi, which leads to the accumulation of lanosterol and other methylated sterols and a decrease in ergosterol concentration. Depletion of ergosterol in the membrane disrupts the structure and function of the fungal cell leading to a decrease or inhibition of fungal growth.
1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine
Terconazole Use and Manufacturing
Terazol (Ortho-McNeil).
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:532.5
XLogP3:4.8
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:8
Exact Mass:531.1803953
Monoisotopic Mass:531.1803953
Topological Polar Surface Area:64.9
Heavy Atom Count:36
Complexity:693
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Extract from the above information
Registered Holders
-
W R GRACE AND CO -CONN
Active
United States
-
QUIMICA SINTETICA SA
Active
Spain
-
Shanghai Shyndec Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Terconazole
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 67915-31-5Grade: Industrial GradeContent: 99%
Latest News on Terconazole
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
Fluocinolone
807-38-5
-
2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, 2-ethylhexyl 2-propenoate and 2-propenoic acid
42398-14-1
-
(3S,7R)-N-[(2-fluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
1863916-87-3
-
1,1-Cyclopropanedicarboxylic acid, 1,1-dimethyl ester Formula
6914-71-2
-
(6R,7R)-7-[[2-amino-2-(cyclohexen-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Formula
37051-00-6
-
3-Hydroxy-4-Methyl-2(5H)-thiophenone Formula
34876-35-2
-
10-Methoxy-5H-dibenz[b,f]azepine-5-carbonyl chloride Structure
28721-08-6
-
3,7-Dihydro-3,7-dimethyl-1-(2-propen-1-yl)-1H-purine-2,6-dione Structure
2530-99-6
-
What is 1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-3,4-dihydrocarbostyril
1797983-65-3
-
What is 3,5-DIIODO-4'-(4-HYDROXYPHENOXY)BENZOICACID
2055-97-2